PATENT CLAIM ANALYSIS

Application Number: 15870376
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "015200"]

Abstract:
The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.

Claim (Index 4):
The method of  claim 2 , wherein said variant of albumin, or fusion polypeptide comprising said variant albumin has a shorter serum half-life than an albumin having the sequence of SEQ ID NO: 2 or fusion polypeptide comprising said albumin having the sequence of SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 86.0
- Lexical Diversity: 1.34615
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13504326', '13640235', '13463944', '14685112', '14385631']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7915956566604981
- 35 USC 102 Novelty (BERT): 0.6312847690632079
- Combined Prediction Score: 0.7755645679007692
- Mean Citation Score: 589.003614
- Max Citation Score: 698.8859
- Similarity Product: 523.0113635080337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test